Martin raised the firm's price target on Amazon to $250 from $210 and affirmed a buy rating on the shares ahead of the firm's ...

Amazon.com has decided to terminate its secret project aimed at developing an at-home fertility tracker. The project, known internally as “Encore,” was part of Amazon’s Grand Challenge division.

The project originated from Amazon's acquisition of bluDiagnostics in 2020, a startup known for its saliva-based fertility ...